bioRxivCell BiologyPreprint
An Aurora Kinase-Dependent Role for Vif in Regulating HIV-1-Induced Cell-Cell Fusion
Samantha Tafrate, Brickley Littell, Jon P. Girard, Emily R. Mynar, Madeline K Carr, Markus ThaliiD, Menelaos SymeonidesiD
Abstract
Viral infectivity factor (Vif) is an HIV-1 accessory protein best known for its counteraction of APOBEC3 enzymes, interferon-inducible host defenses against viral infection, as well as PPP2R5A-E, which are regulatory subunits of the PP2A cellular phosphatase holoenzyme, resulting in striking Vif-dependent phosphoproteome remodeling. One reported consequence of this remodeling is hyperphosphorylation of several Aurora kinase substrates in HIV-1 infected cells, which is reversed when Vif-deficient virus is used. We previously showed that infection of T cells with Vif-deficient HIV-1 results in significantly accelerated formation of syncytia compared to wild-type HIV-1 infection. More recently, others have shown that application of Aurora kinase B inhibitors during HIV-1 infection in T cells also results in a similar hyperfusogenic phenotype. Both effects were specific to Env-driven cell-cell fusion, and did not influence virus infectivity. We thus hypothesized that Vifs influence on the rate of HIV-1-induced cell-cell fusion was mediated by Aurora kinase activity. To start testing this hypothesis, we have evaluated the effects of a small panel of Aurora kinase inhibitors on HIV-1-induced cell-cell fusion in the presence or absence of Vif. Our results replicate the previously documented increase in cell-cell fusion in the absence of Vif, as well as the increase in cell-cell fusion observed upon inhibition of Aurora kinase B in the presence of Vif. Critically, we now present evidence that Vif deletion significantly blunts the impact of Aurora kinase inhibition on cell-cell fusion, supporting our hypothesis that Vif-mediated regulation of cell-cell fusion depends on Aurora kinase signaling dysregulation, likely because of PPP2R5A-E degradation. Further, we document that the cell-cell fusion regulator downstream of Aurora kinase signaling is likely Ezrin, which we have previously shown to prevent excess HIV-1-induced syncytium formation when in its phosphorylated (activated) state. Taken together, these findings establish a Vif, Aurora kinase, and Ezrin-dependent mechanistic framework for the regulation of HIV-1-induced cell-cell fusion in infected T cells which likely helps preserve optimal cell-to-cell virus transmission.
- organism: human
- assay: proteomics
- research focus: host-pathogen & immune response
- approach: experimental assay
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Antagonism of PP2A is an independent and conserved function of HIV-1 Vif and causes cell cycle arrest
S. Marelli, J. C. Williamson, … N. J. Matheson·bioRxiv·Oct 31, 2019
- HIV-1 Vif protein is stabilized by AKT-mediated phosphorylation to enhance APOBEC3G degradation
R. Raja, C. Wang, A. C. Banerjea·bioRxiv·Sep 28, 2021
- HIV-1 Vif disrupts phosphatase feedback regulation at the kinetochore, leading to a pronounced pseudo-metaphase arrest
Dhaval Ghone, Edward L. Evans, … Aussie Suzuki·eLifePeer-reviewed·Mar 13, 2025
- APOBEC3 degradation is the primary function of HIV-1 Vif for virus replication in the myeloid cell line THP-1
T. Ikeda, R. Shimizu, … R. S. Harris·bioRxiv·Mar 28, 2023
- EWI-2 Inhibits Cell-Cell Fusion at the HIV-1 Virological Presynapse
E. E. Whitaker, N. J. Matheson, … M. Thali·bioRxiv·Oct 15, 2019
- APOBEC3 antagonism fully explains HIV-1 Vif essentiality under interferon and differentiation conditions
Ryo Shimizu, Michael Jonathan, … Terumasa Ikeda·bioRxiv·Apr 17, 2026